FDA Kicks Off Program to Expand Access to Investigational Cancer Drugs

Drug Industry Daily
A A
The FDA has launched a new pilot program designed to help healthcare professionals request patient access to unapproved cancer therapies.

To View This Article:

Login

Subscribe To Drug Industry Daily